Propella Therapeutics Inc., a leader in the development of innovative best-in-class prescription products, today announced the issuance of a U.S. patent for a new drug treatment for metastatic prostate cancer. The patent covers new molecules that are designed to provide significant advantages over the current standard of care.
A review of the high-concentration capsaicin patch and experience in its use in the management of neuropathic pain
/in references (CGS-200-5) /by georgePharmacokinetic Analysis of Capsaicin After Topical Administration of a High-Concentration Capsaicin Patch to Patients With Peripheral Neuropathic Pain
/in references (CGS-200-5) /by georgeTopical capsaicin (high concentration) for chronic neuropathic pain in adults
/in references (CGS-200-5) /by georgePharmacokinetic and The Effect of Capsaicin in Capsicum
/in references (CGS-200-5) /by georgefrutescens on Decreasing Plasma Glucose Level
frutescens on Decreasing Plasma Glucose Level
Spicy Pepper Consumption and Preferences in the United States
/in references (CGS-200-5) /by georgeCapsaicin for Osteoarthritis Pain
/in references (CGS-200-5) /by georgeA Comprehensive Review of the Carcinogenic and Anticarcinogenic Potential of Capsaicin
/in references (CGS-200-5) /by georgeTopical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch
/in references (CGS-200-5) /by georgePress Release: Propella Therapeutics Granted U.S. Patent for New Treatment for Metastatic Prostate Cancer
/in press releases /by altusdevsite_4grsdfPropella Therapeutics Inc., a leader in the development of innovative best-in-class prescription products, today announced the issuance of a U.S. patent for a new drug treatment for metastatic prostate cancer. The patent covers new molecules that are designed to provide significant advantages over the current standard of care.
Unravelling the Mystery of Capsaicin: A Tool to Understand and Treat Pain
/in references (CGS-200-5) /by george